Features of diet therapy for H. pylori associated diseases of the gastrointestinal tract
Open Access
- 5 October 2022
- journal article
- review article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 15,p. 46-61
Abstract
This review of the literature is devoted to the importance of nutritional support in the treatment and prevention of diseases of the gastrointestinal tract associated with Helicobacter pylori. Modern data on the biological properties of H. pylori and the mechanisms of colonization of the microorganism in the gastrointestinal mucosa are presented. Information is provided on the virulence factors and factors that promote adhesion, depolymerization and dissolution of protective mucus, damage and circulatory disorders of the gastrointestinal mucosa, secreted by H. pylori (lipopolysaccharides and proteins of the outer shell of the bacterium, enzymes – mucinase, protease, phospholipase, urease, VacA cytotoxin). The article pays special attention to the issues of diet therapy, the role of various foods and their components in the dietary correction of disorders in gastrointestinal diseases associated with H. pylori. The causes of nutritional disorders in patients with gastrointestinal diseases are described and a detailed description of food products and their biologically active components with anti-Helicobacter activity is given. A special section is devoted to the use and effectiveness of specialized dietary products for therapeutic and preventive nutrition of domestic production (LLC “Leovit nutria”) and the features of use in diseases of the gastrointestinal tract mediated by H. pylori. The authors provide information on the composition of dietary products, their anti-inflammatory, antioxidant, immunotropic and other activities that underlie clinical efficacy. The article provides detailed recommendations on the use of specialized dietary foods for this pathology.Keywords
This publication has 98 references indexed in Scilit:
- Anti-Helicobacter pylori Potential of Artemisinin and Its DerivativesAntimicrobial Agents and Chemotherapy, 2012
- The gastric precancerous cascadeJournal of Digestive Diseases, 2011
- BabA-mediated Adherence Is a Potentiator of the Helicobacter pylori Type IV Secretion System ActivityJournal of Biological Chemistry, 2011
- Regulation of p53 Tumor Suppressor by Helicobacter pylori in Gastric Epithelial CellsGastroenterology, 2010
- Helicobacter pylori: gastric cancer and beyondNature Reviews Cancer, 2010
- Response of Gastric Epithelial Progenitors to Helicobacter pylori Isolates Obtained from Swedish Patients with Chronic Atrophic GastritisJournal of Biological Chemistry, 2009
- Green tea inhibits Helicobacter growth in vivo and in vitroInternational Journal of Antimicrobial Agents, 2009
- Exploring the cost‐effectiveness ofHelicobacter pyloriscreening to prevent gastric cancer in China in anticipation of clinical trial resultsInternational Journal of Cancer, 2008
- Regulation of Gastric Carcinogenesis by Helicobacter pylori Virulence FactorsCancer Research, 2008
- Pathogenesis ofHelicobacter pyloriInfectionClinical Microbiology Reviews, 2006